Experimental Therapies and Ongoing Clinical Trials to Slow Down Progression of ADPKD
نویسندگان
چکیده
منابع مشابه
Adding Experimental Arms to Ongoing Clinical Trials
Multi-arm clinical trials use a single control arm to evaluate multiple experimental treatments. In most cases this feature makes multi-arm studies considerably more efficient than two-arm studies that evaluate single experimental treatments. A bottleneck for implementation is the requirement that experimental treatments need to be available at the enrollment of the first patient. New drugs are...
متن کاملEmerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Pulmonary arterial hypertension (PAH) is a rare, progressive disorder that leads to an inexorable rise in pulmonary vascular resistance, ultimately resulting in right ventricular failure and death if left untreated. Currently available pulmonary vasoremodeling therapy has significantly improved morbidity and mortality in PAH. However, 3-year mortality in PAH is still higher than in many other c...
متن کاملClinical trials of neuroprotective therapies.
There have been numerous failures in the field of acute stroke therapy over many years, but the first large clinical trial showing preliminary indications of efficacy and safety of a neuroprotective drug, NXY-059, has now been fully reported. If confirmed, it will mean that a second therapy for acute stroke has been identified and neuroprotective drug development as a class can proceed. Additio...
متن کاملPersian Medicine Herbal Therapies for Osteoarthritis: a Review of Clinical Trials
Osteoarthritis (OA) of the knee is one of the important medical complications in elderly peoples. Various pharmacological and non-pharmacological therapies are described for treatment of knee OA, but considerable side effects especially in old populations are the limiting factors. Traditional, complementary and integrative medicines have a long history in treatment of chronic diseases such as O...
متن کاملSpecial Feature Ongoing Clinical Trials in AKI
AKI is an important public health issue. AKI is a common hospital complication associated with increased inhospital and long-term mortality, extensive morbidity (including prolonged hospital length of stay), and an estimated annual cost of at least $10 billion in the United States. At present, no specific therapy has been developed to prevent AKI, hasten recovery of kidney function, or abrogate...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Hypertension Reviews
سال: 2013
ISSN: 1573-4021
DOI: 10.2174/1573402111309010008